<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03037632</url>
  </required_header>
  <id_info>
    <org_study_id>2015H0309</org_study_id>
    <secondary_id>R01HL128857</secondary_id>
    <nct_id>NCT03037632</nct_id>
  </id_info>
  <brief_title>DCM Precision Medicine Study</brief_title>
  <official_title>Precision Medicine for Dilated Cardiomyopathy in European and African Ancestry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ray Hershberger</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Human Genome Research Institute (NHGRI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Ohio State University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aims of the DCM Precision Medicine Study are to test the hypothesis that DCM has&#xD;
      substantial genetic basis and to evaluate the effectiveness of a family communication&#xD;
      intervention in improving the uptake and impact of family member clinical screening.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Dilated cardiomyopathy of unknown cause (DCM), known clinically as idiopathic dilated&#xD;
      cardiomypathy, is the most common cardiomyopathy and is the leading cause of heart&#xD;
      transplantation. DCM affects approximately one million individuals, and so has a major impact&#xD;
      on US public health. DCM is commonly asymptomatic until very late in its course when it&#xD;
      causes heart failure, disability, and death. Because of its clinical course, any means to&#xD;
      identify patients at risk for DCM or to detect DCM in its asymptomatic phase could provide&#xD;
      enormous opportunity for intervention to extend lives and prevent late-stage disease. Within&#xD;
      this paradigm precision medicine for DCM could greatly impact health care outcomes and costs.&#xD;
      Recent advances in DCM genetics have introduced these possibilities, but unresolved questions&#xD;
      of familial recurrence risk, genetic etiology, racial differences, and family-based screening&#xD;
      must be addressed to move ahead. The central hypothesis of this study, based on published&#xD;
      studies of the investigative group, states that DCM has substantial genetic basis. For this&#xD;
      study the investigators hypothesize that: (a) 35% of probands of both European and African&#xD;
      ancestry (EA/AA) will be classified as familial in a cohort recruited in a multicenter US&#xD;
      consortium and given explicit recommendations and assistance to achieve the clinical&#xD;
      screening of relatives; (b) approximately 40% of DCM probands, whether categorized as&#xD;
      familial or non-familial, or as EA or AA, will have pathogenic or likely pathogenic variants&#xD;
      in genes previously implicated in DCM; and (c) a tailored intervention to help DCM probands&#xD;
      communicate DCM risk to their family members will improve the uptake and impact of necessary&#xD;
      clinical and genetic testing. To test these hypotheses, the investigators propose to: (1)&#xD;
      estimate and compare the frequencies of EA and AA DCM probands classified as having familial&#xD;
      DCM; (2) estimate and compare the proportions of probands with an identifiable genetic cause&#xD;
      of DCM in groups defined by proband classification (familial/non-familial) and ancestry&#xD;
      (EA/AA); and (3) evaluate the impact of a randomized intervention to aid and direct family&#xD;
      communication on participation of at-risk family members in clinical screening and&#xD;
      appropriate follow-up surveillance for DCM. These aims will be accomplished by recruiting a&#xD;
      cohort of 1300 DCM probands (600 EA, 600 AA, 100 Hispanic ethnicity), performing&#xD;
      cardiovascular clinical screening of 2600 family members, performing genetic testing of&#xD;
      probands and affected family members by exome sequencing, returning genetic results, and&#xD;
      randomizing probands to an intervention to improve family communication regarding DCM risk.&#xD;
      Proving these hypotheses would be transformative for the field: rather than viewing DCM as&#xD;
      only a clinical diagnosis, cardiovascular professionals would understand DCM as a genetic&#xD;
      disease that should be managed using genetic diagnostic and family-based preventive&#xD;
      strategies. These study results would make precision medicine for DCM a reality.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 7, 2016</start_date>
  <completion_date type="Anticipated">April 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>Blinded until intervention is assigned to subject.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Family clinical screening completed within 12 months from proband enrollment.</measure>
    <time_frame>12 months from proband enrollment.</time_frame>
    <description>The probability that a living first-degree relative (FDR) without a previous definitive DCM diagnosis completes clinical screening for DCM within 12 months after proband recruitment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Living first-degree relative adheres to cardiovascular surveillance recommendations after return of genetic results.</measure>
    <time_frame>2.5 years</time_frame>
    <description>The probability that a living first-degree relative adheres to surveillance recommendations within 15 months after the proband receives individual genetic test information.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">6500</enrollment>
  <condition>Idiopathic Dilated Cardiomyopathy</condition>
  <arm_group>
    <arm_group_label>Communication Tool</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>No Communication Tool</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Family Heart Talk Booklet</intervention_name>
    <arm_group_label>Communication Tool</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Meeting criteria for dilated cardiomyopathy (DCM) :&#xD;
&#xD;
               -  Left ventricular ejection fraction &lt;50%&#xD;
&#xD;
               -  Left ventricular enlargement (A left ventricular end-diastolic dimension &gt;&#xD;
                  95%tile population standard based on gender and height).&#xD;
&#xD;
          -  Detectable causes of cardiomyopathy, except genetic, excluded beyond a reasonable&#xD;
             doubt at the time of DCM diagnosis (that is, meeting clinical criteria for idiopathic&#xD;
             DCM)&#xD;
&#xD;
          -  Any age (including children)&#xD;
&#xD;
          -  Non-Hispanic and Hispanic ethnicity&#xD;
&#xD;
          -  All races (PI pre-approval required for recruitment beyond pre-specified recruitment&#xD;
             targets).&#xD;
&#xD;
          -  Ability to give informed consent&#xD;
&#xD;
          -  Ability to communicate in English (except Spanish language at sites approved to&#xD;
             recruit individuals of Hispanic ethnicity)&#xD;
&#xD;
          -  Willingness to participate in a family-based study (patient willing to work with a&#xD;
             clinical site and/or OSU to facilitate the recruitment and enrollment of family&#xD;
             members to the study).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Coronary artery disease (CAD) causing ischemic cardiomyopathy (&gt; 50% narrowing, any&#xD;
             major epicardial coronary artery)&#xD;
&#xD;
          -  Primary valvular disease&#xD;
&#xD;
          -  Adriamycin or other cardiotoxic drug exposure&#xD;
&#xD;
          -  Other forms of cardiomyopathy: Hypertrophic, Restrictive, or Arrhythmogenic Right&#xD;
             Ventricular Dysplasia/Cardiomyopathy&#xD;
&#xD;
          -  Congenital heart disease&#xD;
&#xD;
          -  Other detectable causes of dilated cardiomyopathy, including sarcoid and&#xD;
             hemochromatosis.&#xD;
&#xD;
          -  Other active multi-system disease that may cause DCM (e.g., active connective tissue&#xD;
             disease).&#xD;
&#xD;
          -  Severe and untreated or untreatable hypertension (systolic blood pressures routinely&#xD;
             greater than 180 mm Hg and/or diastolic blood pressures greater than 120 mm Hg, and if&#xD;
             resistant to multidrug treatment).&#xD;
&#xD;
          -  However, conventional risk factors for DCM, including obesity, routinely treated&#xD;
             hypertension, alcohol use, pregnancy or the peri-partum period, or left ventricular&#xD;
             noncompaction, will NOT be considered exclusion criteria.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ray Hershberger, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ohio State University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Principal Investigator</last_name>
    <phone>614-688-1388</phone>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Clinical Research Manager</last_name>
    <phone>614-688-9815</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Salpy Pamboukian, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Clinical Research Coordinator</last_name>
      <phone>205-934-3438</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University of Arizona Sarver Heart Center</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85724</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Research Coordinator</last_name>
      <phone>520-626-7761</phone>
    </contact>
    <investigator>
      <last_name>Nancy Sweitzer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cedars-Sinai Medical Center</name>
      <address>
        <city>Beverly Hills</city>
        <state>California</state>
        <zip>90211</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Evan Kransdorf, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Clinical Research Coordinator</last_name>
      <phone>310-248-7132</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>UCLA Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessica Wang, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Clinical Research Coordinator</last_name>
      <phone>310-825-8816</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Research Coordinator</last_name>
      <phone>415-430-7391</phone>
    </contact>
    <investigator>
      <last_name>Matthew Wheeler, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medstar Washington Hospital Center (DC)</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Research Coordinator</last_name>
      <phone>202-877-0613</phone>
    </contact>
    <investigator>
      <last_name>Mark Hofmeyer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>South Miami Heart Center</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Research Coordinator</last_name>
      <phone>786-662-8467</phone>
    </contact>
    <investigator>
      <last_name>Javier Jimenez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emory University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Research Coordinator</last_name>
      <phone>404-712-0502</phone>
    </contact>
    <investigator>
      <last_name>Alanna Morris, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Research Coordinator</last_name>
      <phone>312-695-4965</phone>
    </contact>
    <investigator>
      <last_name>Jane Wilcox, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Louisiana State University Health Sciences Center in New Orleans</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Research Coordinator</last_name>
      <phone>504-568-2637</phone>
    </contact>
    <investigator>
      <last_name>Frank Smart, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Maryland</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Research Coordinator</last_name>
      <phone>410-868-1575</phone>
    </contact>
    <investigator>
      <last_name>Stephen Gottlieb, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tufts Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Research Coordinator</last_name>
      <phone>617-636-4884</phone>
    </contact>
    <investigator>
      <last_name>Gordon Huggins, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48187</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Research Coordinator</last_name>
      <phone>734-232-4606</phone>
    </contact>
    <investigator>
      <last_name>Keith Aaronson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Henry Ford Health Systems</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Lanfear, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Clinical Research Coordinator</last_name>
      <phone>313-874-1887</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University of Mississippi Medical Center</name>
      <address>
        <city>Jackson</city>
        <state>Mississippi</state>
        <zip>39216</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Research Coordinator</last_name>
      <phone>601-815-8702</phone>
    </contact>
    <investigator>
      <last_name>Charles Moore, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Washington University in St. Louis</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Research Coordinator</last_name>
      <phone>314-286-0541</phone>
    </contact>
    <investigator>
      <last_name>Gregory Ewald, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Nebraska Medical Center</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68198</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Research Coordinator</last_name>
      <phone>402-559-8862</phone>
    </contact>
    <investigator>
      <last_name>Brian Lowes, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NYU School of Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Research coordinator</last_name>
      <phone>646-501-0119</phone>
    </contact>
    <investigator>
      <last_name>Stephen Pan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Research Coordinator</last_name>
      <phone>216-636-6153</phone>
    </contact>
    <investigator>
      <last_name>Wilson Tang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Research Manager</last_name>
      <phone>614-688-9815</phone>
      <email>DCM.Research@osumc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Co-Investigator</last_name>
      <phone>614-688-9340</phone>
      <email>DCM.Research@osumc.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Ray Hershberger, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Research Coordinator</last_name>
      <phone>215-615-3236</phone>
    </contact>
    <contact_backup>
      <last_name>Clinical Research Coordinator</last_name>
      <phone>215-662-4214</phone>
    </contact_backup>
    <investigator>
      <last_name>Anjali Owens, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Judge, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Clinical Research Coordinator</last_name>
      <phone>843-792-1659</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sonia Garg, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Clinical Research Coordinator</last_name>
      <phone>214-645-8040</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Houston Methodist Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Research Coordinator</last_name>
      <phone>713-441-3910</phone>
    </contact>
    <investigator>
      <last_name>Barry H Trachtenberg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Omar Wever-Pinzon, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Clinical Research Coordinator</last_name>
      <phone>801-213-3417</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Inova Heart and Vascular Institute</name>
      <address>
        <city>Fairfax</city>
        <state>Virginia</state>
        <zip>22042</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Research Coordinator</last_name>
      <phone>703-776-3697</phone>
    </contact>
    <investigator>
      <last_name>Palak Shah, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Washington</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Research Coordinator</last_name>
      <phone>206-685-4346</phone>
    </contact>
    <investigator>
      <last_name>Daniel Fishbein, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://DCMProject.com</url>
    <description>Additional information regarding DCM Precision Medicine Study information provided on website.</description>
  </link>
  <reference>
    <citation>Kinnamon DD, Morales A, Bowen DJ, Burke W, Hershberger RE; DCM Consortium*. Toward Genetics-Driven Early Intervention in Dilated Cardiomyopathy: Design and Implementation of the DCM Precision Medicine Study. Circ Cardiovasc Genet. 2017 Dec;10(6). pii: e001826. doi: 10.1161/CIRCGENETICS.117.001826.</citation>
    <PMID>29237686</PMID>
  </reference>
  <reference>
    <citation>Morales A, Kinnamon DD, Jordan E, Platt J, Vatta M, Dorschner MO, Starkey CA, Mead JO, Ai T, Burke W, Gastier-Foster J, Jarvik GP, Rehm HL, Nickerson DA, Hershberger RE; DCM Precision Medicine study of the DCM Consortium; DCM Consortium institutions and personnel participating in this study: Study Principal Investigator and Co-Investigators,DCM Consortium Clinical Site Principal Investigators and Clinical Site Other Significant Contributors (OSC). The following clinical sites and individuals contributed to the submission of RO 1 H L 128857 as Site Principal Investigators (Site Pl) or as Other Significant Contributors (OSC),Dr. Huggins also served as study co-principal investigator,The following clinical site was added following approval of NHGRI supplemental funding but prior to initiation of enrollment,The following clinical sites were added following study activation. Variant Interpretation for Dilated Cardiomyopathy: Refinement of the American College of Medical Genetics and Genomics/ClinGen Guidelines for the DCM Precision Medicine Study. Circ Genom Precis Med. 2020 Apr;13(2):e002480. doi: 10.1161/CIRCGEN.119.002480. Epub 2020 Mar 11.</citation>
    <PMID>32160020</PMID>
  </reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>January 27, 2017</study_first_submitted>
  <study_first_submitted_qc>January 27, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 31, 2017</study_first_posted>
  <last_update_submitted>September 8, 2021</last_update_submitted>
  <last_update_submitted_qc>September 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Ohio State University</investigator_affiliation>
    <investigator_full_name>Ray Hershberger</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiomyopathies</mesh_term>
    <mesh_term>Cardiomyopathy, Dilated</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

